addresses at how this translates to pharmacological treatment of adult spasticity, including injections with botulinum toxin A … regarding mean BoNT-A treatment dose and proportion used for spasticity indication were validated in five county councils, while … variation in pharmacologic treatment of adult spasticity in Sweden. Overall, the results indicate an underuse of treatment and …

addresses at how this translates to pharmacological treatment of adult spasticity, including injections with botulinum toxin A … regarding mean BoNT-A treatment dose and proportion used for spasticity indication were validated in five county councils, while … variation in pharmacologic treatment of adult spasticity in Sweden. Overall, the results indicate an underuse of treatment and …

-stroke spasticity of the upper limb and evaluate treatment effectiveness and tolerability as well as costs over the treatment period of … incobotulinumtoxinA (INCO) treatment (n = 118) to conventional (CON) antispastic therapy (n = 110) for upper limb spasticity after stroke … guideline recommendations for botulinum toxin A treatment in focal or segmental spasticity. Results may partially be influenced …

-stroke spasticity of the upper limb and evaluate treatment effectiveness and tolerability as well as costs over the treatment period of … incobotulinumtoxinA (INCO) treatment (n = 118) to conventional (CON) antispastic therapy (n = 110) for upper limb spasticity after stroke … guideline recommendations for botulinum toxin A treatment in focal or segmental spasticity. Results may partially be influenced …

sclerosis improved the spasticity of patients previously treated with interferon-β. However, whether such an improvement was …-β in these patients with multiple sclerosis and spasticity. Methods: This cost analysis encompassed data from the … observational Escala Study, which included patients with relapsing-remitting multiple sclerosis and spasticity whose treatment had …

sclerosis improved the spasticity of patients previously treated with interferon-β. However, whether such an improvement was …-β in these patients with multiple sclerosis and spasticity. Methods: This cost analysis encompassed data from the … observational Escala Study, which included patients with relapsing-remitting multiple sclerosis and spasticity whose treatment had …